Antiarthritic activity of a standardized, multiherbal, ayurvedic formulation containing Boswellia serrata: In vitro studies on knee cartilage from osteoarthritis patients

Phytotherapy Research

Volumn 25, Issue 9, 2011, Pages 1375-1380

  Sumantran, V N ^a   Joshi, A K ^a   Boddul, S ^a   Koppikar, S J ^a   Warude, D ^a   Patwardhan, B ^b   Chopra, A ^c   Chandwaskar, R ^a   Wagh, U V ^a  

^a Bharati Vidyapeeth   (India)

^b UNIVERSITY OF PUNE   (India)

^c Center for Rheumatic Diseases   (India)

Author keywords

aggrecan; Boswellia serrata; glucosamine sulphate; osteoarthritis

Indexed keywords

AGGRECAN; AYURVEDIC DRUG; BOSWELLIA SERRATA EXTRACT; EMBLICA OFFICINALIS EXTRACT; GINGER EXTRACT; GLUCOSAMINE SULFATE; GLYCOSAMINOGLYCAN; NITRIC OXIDE; TINOSPORA CORDIFOLIA EXTRACT; ANTIINFLAMMATORY AGENT; OLEORESINS; PLANT EXTRACT; PLANT MEDICINAL PRODUCT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; EXPLANT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KNEE OSTEOARTHRITIS; PROTEIN SECRETION; AYURVEDA; BOSWELLIA; CHEMISTRY; DRUG EFFECTS; KNEE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS;

BOSWELLIA SERRATA; PHYLLANTHUS EMBLICA; TINOSPORA CORDIFOLIA; ZINGIBER OFFICINALE;

AGED; AGGRECANS; ANTI-INFLAMMATORY AGENTS; BOSWELLIA; CARTILAGE, ARTICULAR; GLYCOSAMINOGLYCANS; HUMANS; IN VITRO TECHNIQUES; KNEE JOINT; MEDICINE, AYURVEDIC; MIDDLE AGED; NITRIC OXIDE; OSTEOARTHRITIS; PLANT EXTRACTS; PLANT PREPARATIONS;

EID: 80052295856     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3365     Document Type: Article

References (27)

1. Altman RD, Marcussen KC,. 2001. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44: 2531-2538. (Pubitemid 33049331)
2. Cameron M, Gagnier JJ, Little CV, Parsons TJ, Blümle A, Chrubasik S,. 2009. Evidence of effectiveness of herbal medicinal products in the treatment of arthritis. Part 1: Osteoarthritis. Phytother Res 23: 1497-1515.
3. Chopra A, Saluja M, Tillu G, Venugopalan V, Sarmukaddam S, Raut AK, Bichile L, Narsimulu G, Handa G, Patwardhan B,. 2010. A randomized controlled exploratory evaluation of standardized Ayurvedic formulations in symptomatic osteoarthritis knees: A Government of India NMITLI Project. Evid Based Complement Alternat Med 2011: 1-12.
4. Dodge R, Jimenez SA,. 2003. Glucosamine sulfate modulates the levels of the aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage 11: 424-432. (Pubitemid 36722656)
5. Ernst E,. 2008. Frankincense: A systematic review. Br Med J 337: 2813-2816.
6. Ganju L, Karan D, Chanda S, Srivastava KK, Sawhney RC, Selvamurthy W,. 2003. Immunomodulatory effects of agents of plant origin. Biomed Pharmacother 57 (7): 296-300. (Pubitemid 37123101)
7. Griess P,. 1879. Bemerkungen zu der Abhandlung der HH. Weselky und Benedikt Ueber einige Azoverbindungen. Ber Dtsch Chem Ges 12: 426-428. doi: 10.1002/cber.187901201117.
8. Hoemann CD, Sun J, Chrzanowski V, Bushman MD,. 2002. A multivalent assay detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300: 1-10. (Pubitemid 34066797)
9. Jagetia GC, Baliga MS,. 2004. The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study. J Med Food 7: 343-348. (Pubitemid 39299495)
10. Kimmatkar N, Thawani V, Hingorani L, Khivani R,. 2003. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine 10: 3-7. (Pubitemid 36262200)
11. Liacini A, Sylvester J, Zafarullah M,. 2005. Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes. Biochem Biophys Res Commun 327: 320-332.
12. Little CB, Flannery CR, Hughes CE, et al., 1999. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 344: 61-68.
13. Mathy-Hartet M, Deby-Dupont GP, Reginster JY, Ayache N, Pujol JP, Henrotin YE,. 2002. Regulation by reactive oxygen species of interleukin-1beta, nitric oxide and prostaglandin E(2) production by human chondrocytes. Osteoarthritis Cartilage 10: 547-555. (Pubitemid 34919070)
14. Mathy-Hartert M, Jacquemond-Collet I, Priem F, Sanchez C, Lambert C, Henrotin Y,. 2009. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res 58: 899-908.
15. Nair PK, Rodriguez S, Ramachandran R, Alamo A, Melnick SJ,. 2004. Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia. Int Immunopharmacol 4: 1645-1659. (Pubitemid 39348862)
16. Outerbridge RE,. 1961. The etiology of chondromalacia patellae. J Bone Joint Surg 43B: 752-757.
17. Poole AR, Ionescu M, Swan A, Dieppe PA,. 2000. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of cartilage proteoglycan aggrecan. J Clin Invest 94: 25-33.
18. Reddy GK, Chandrakasan G, Dhar SC,. 1989. Studies on the metabolism of glycosaminoglycans under the influence of new herbal anti-inflammatory agents. Biochem Pharmacol 38: 3527-3534. (Pubitemid 19250206)
19. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP,. 1992. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261: 1143-1146.
20. Sengupta K, Alluri KV, Satish AR, et al,. 2008. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthritis Res Ther 10: 1-11.
21. Squires GR, Okuneff S, Lonescu M, Poole AR,. 2003. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum 48: 1261-1270. (Pubitemid 36554525)
22. Stevens AL, Wheeler CA, Tannenbaum SR, Grodzinsky AJ,. 2008. Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Osteoarthritis Cartilage 16: 489-497. (Pubitemid 351426265)
23. Struglics A, Larsson S, Pratta MA, Kumar S, Lark MW, Lohmander LS,. 2006. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. Osteoarthritis Cartilage 14: 101-113. (Pubitemid 43079306)
24. Sumantran VN, Chandwaskar R, Joshi AK, et al,. 2008b. The relationship between chondroprotective and anti-inflammatory effects of Withania somnifera root and glucosamine sulphate on human osteoarthritic cartilage in vitro. J Phytother Res 10: 1342-1348.
25. Sumantran VN, Kulkarni A, Chandwaskar RC, et al,. 2008a. Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis. Evid Based Complement Altern Med 5: 329-335.
26. Uitterlinden EJ, Jahr K, Koevoet JL, et al,. 2006. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage 14: 250-257. (Pubitemid 43329534)
27. Vankemmelbeke MN, Jones GC, Fowles C, et al,. 2003. Selective inhibition of ADAMTS-1, -4 and -5 by catechin gallate esters. Eur J Biochem 270: 2394-2403. (Pubitemid 36645357)